Search Results 1341-1350 of 17896 for monoclonal antibody
... monoclonal antibody, small molecule pathway inhibitor). Treatment with systemic corticosteroid or immune-modulators ≤ 7 days prior to randomization ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...
Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
I'm Dr. Halena Gazelka. April is Donate Life month. When it comes to organ transplantation, patients with high levels of antibodies, also called highly ...
Participation eligibility · Clinical evidence of acutely infected pyoderma gangrenosum · History of allergic or anaphylactic reactions to monoclonal antibodies ...
Participation eligibility · History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the ...
Medina, Ph.D., studies B lymphocyte biology. B lymphocytes are a special category of white blood cells that produce antibodies to fight infection. Defects in B ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!